1,2-dimethylhydrazine increases expression ISO RGD:1551257 6480464 1, 2-Dimethylhydrazine results in increased expression of NRP2 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:1551257 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of NRP2 mRNA] CTD PMID:22206623 17beta-estradiol multiple interactions ISO RGD:732191 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of NRP2 mRNA CTD PMID:30165855 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:732191 6480464 2 more ... CTD PMID:23146750 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:27291303 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1551257 6480464 Tetrachlorodibenzodioxin affects the expression of NRP2 mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of NRP2 mRNA CTD PMID:32109520 2-butoxyethanol decreases expression ISO RGD:1551257 6480464 n-butoxyethanol results in decreased expression of NRP2 mRNA CTD PMID:19812364 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:732191 6480464 3 more ... CTD PMID:23146750 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:732191 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NRP2 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO RGD:1551257 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of NRP2 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide increases expression ISO RGD:1551257 6480464 Fenretinide results in increased expression of NRP2 mRNA CTD PMID:28973697 acetamide increases expression EXP 6480464 acetamide results in increased expression of NRP2 mRNA CTD PMID:31881176 aflatoxin B1 increases methylation ISO RGD:732191 6480464 Aflatoxin B1 results in increased methylation of NRP2 polyA tail CTD PMID:30157460 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of NRP2 mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO RGD:732191 6480464 Antirheumatic Agents results in decreased expression of NRP2 mRNA CTD PMID:24449571 arsane affects expression ISO RGD:732191 6480464 Arsenic affects the expression of NRP2 protein CTD PMID:24675094 arsane affects methylation ISO RGD:732191 6480464 Arsenic affects the methylation of NRP2 gene CTD PMID:25304211 arsenic atom affects expression ISO RGD:732191 6480464 Arsenic affects the expression of NRP2 protein CTD PMID:24675094 arsenic atom affects methylation ISO RGD:732191 6480464 Arsenic affects the methylation of NRP2 gene CTD PMID:25304211 benzo[a]pyrene affects methylation ISO RGD:732191 6480464 Benzo(a)pyrene affects the methylation of NRP2 intron, Benzo(a)pyrene affects the methylation of NRP2 polyA tail CTD PMID:30157460 benzo[e]pyrene increases methylation ISO RGD:732191 6480464 benzo(e)pyrene results in increased methylation of NRP2 intron, benzo(e)pyrene results in increased methylation of NRP2 polyA tail CTD PMID:30157460 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of NRP2 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1551257 6480464 bisphenol A results in increased expression of NRP2 mRNA CTD PMID:30951980 bisphenol A increases expression ISO RGD:732191 6480464 bisphenol A results in increased expression of NRP2 mRNA CTD PMID:29275510 bisphenol A multiple interactions ISO RGD:732191 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NRP2 mRNA CTD PMID:28628672 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of NRP2 mRNA CTD PMID:30816183 bisphenol F increases expression ISO RGD:1551257 6480464 bisphenol F results in increased expression of NRP2 mRNA CTD PMID:30951980 calcitriol decreases expression ISO RGD:732191 6480464 Calcitriol results in decreased expression of NRP2 mRNA CTD PMID:16002434 calcitriol increases expression ISO RGD:732191 6480464 Calcitriol results in increased expression of NRP2 mRNA CTD PMID:16002434 chloroprene decreases expression ISO RGD:1551257 6480464 Chloroprene results in decreased expression of NRP2 mRNA CTD PMID:23125180 chlorthalidone decreases expression EXP 6480464 Chlorthalidone results in decreased expression of NRP2 mRNA CTD PMID:20625077 cisplatin increases expression ISO RGD:732191 6480464 Cisplatin results in increased expression of NRP2 mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:732191 6480464 [Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of NRP2 mRNA CTD PMID:30871063 cobalt dichloride decreases expression ISO RGD:732191 6480464 cobaltous chloride results in decreased expression of NRP2 mRNA CTD PMID:19320972 cocaine increases expression EXP 6480464 Cocaine results in increased expression of NRP2 mRNA CTD PMID:15691709 crocidolite asbestos decreases expression ISO RGD:732191 6480464 Asbestos, Crocidolite results in decreased expression of NRP2 mRNA CTD PMID:18687144 cyclophosphamide increases expression EXP 6480464 Cyclophosphamide results in increased expression of NRP2 mRNA CTD PMID:18632792 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of NRP2 mRNA CTD PMID:23640034 dexamethasone multiple interactions ISO RGD:732191 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NRP2 mRNA CTD PMID:28628672 dibutyl phthalate increases expression ISO RGD:1551257 6480464 Dibutyl Phthalate results in increased expression of NRP2 mRNA CTD PMID:17361019 dichlorine multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in increased expression of NRP2 mRNA CTD PMID:18636392 dicrotophos increases expression ISO RGD:732191 6480464 dicrotophos results in increased expression of NRP2 mRNA CTD PMID:28302478 dorsomorphin multiple interactions ISO RGD:732191 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:732191 6480464 Doxorubicin results in decreased expression of NRP2 mRNA CTD PMID:29803840 doxorubicin increases expression ISO RGD:732191 6480464 Doxorubicin results in increased expression of NRP2 mRNA CTD PMID:30031762 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of NRP2 mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:732191 6480464 entinostat results in increased expression of NRP2 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:732191 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA CTD PMID:27188386 ethanol multiple interactions ISO RGD:732191 6480464 [Ethanol co-treated with Folic Acid] results in increased expression of NRP2 mRNA CTD PMID:23378141 ethanol multiple interactions ISO RGD:1551257 6480464 Ethanol affects the expression of and affects the splicing of NRP2 mRNA CTD PMID:30319688 ethanol affects expression ISO RGD:1551257 6480464 Ethanol affects the expression of NRP2 mRNA CTD PMID:30319688 ethanol increases expression ISO RGD:1551257 6480464 Ethanol results in increased expression of NRP2 mRNA CTD PMID:30319688 folic acid multiple interactions ISO RGD:732191 6480464 [Ethanol co-treated with Folic Acid] results in increased expression of NRP2 mRNA CTD PMID:23378141 folic acid decreases expression ISO RGD:732191 6480464 Folic Acid results in decreased expression of NRP2 mRNA CTD PMID:21867686 folic acid multiple interactions ISO RGD:1551257 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of NRP2 mRNA] CTD PMID:22206623 folic acid increases expression ISO RGD:1551257 6480464 Folic Acid results in increased expression of NRP2 mRNA CTD PMID:25629700 fonofos increases methylation ISO RGD:732191 6480464 Fonofos results in increased methylation of NRP2 promoter CTD PMID:22847954 furan increases methylation EXP 6480464 furan results in increased methylation of NRP2 gene CTD PMID:22079235 furan decreases expression ISO RGD:1551257 6480464 furan results in decreased expression of NRP2 mRNA CTD PMID:24183702 genistein affects expression ISO RGD:732191 6480464 Genistein affects the expression of NRP2 mRNA CTD PMID:16399490 hydroquinone O-beta-D-glucopyranoside increases expression ISO RGD:732191 6480464 Arbutin results in increased expression of NRP2 mRNA CTD PMID:17103032 indometacin multiple interactions ISO RGD:732191 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NRP2 mRNA CTD PMID:28628672 kainic acid affects response to substance ISO RGD:1551257 6480464 NRP2 protein affects the susceptibility to Kainic Acid CTD PMID:18657176 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of NRP2 mRNA CTD PMID:28801915 methapyrilene increases methylation ISO RGD:732191 6480464 Methapyrilene results in increased methylation of NRP2 intron, Methapyrilene results in increased methylation of NRP2 polyA tail CTD PMID:30157460 methylmercury chloride increases expression ISO RGD:732191 6480464 methylmercuric chloride results in increased expression of NRP2 mRNA CTD PMID:23179753 more ... methylmercury chloride multiple interactions ISO RGD:732191 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA CTD PMID:27188386 N-acetylsphingosine multiple interactions ISO RGD:732191 6480464 sphingosine 1-phosphate inhibits the reaction [N-acetylsphingosine results in decreased expression of NRP2 mRNA] CTD PMID:15741222 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of NRP2 mRNA CTD PMID:28801915 nickel atom increases expression ISO RGD:732191 6480464 Nickel results in increased expression of NRP2 mRNA CTD PMID:24768652 nickel sulfate increases expression ISO RGD:732191 6480464 nickel sulfate results in increased expression of NRP2 mRNA CTD PMID:16780908 nickel sulfate decreases expression ISO RGD:732191 6480464 nickel sulfate results in decreased expression of NRP2 mRNA CTD PMID:18832182 ozone multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in increased expression of NRP2 mRNA CTD PMID:18636392 p-menthan-3-ol decreases expression ISO RGD:732191 6480464 Menthol results in decreased expression of NRP2 mRNA CTD PMID:26760959 panobinostat multiple interactions ISO RGD:732191 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA CTD PMID:27188386 parathion increases methylation ISO RGD:732191 6480464 Parathion results in increased methylation of NRP2 promoter CTD PMID:22847954 pentetrazol affects response to substance ISO RGD:1551257 6480464 NRP2 protein affects the susceptibility to Pentylenetetrazole CTD PMID:18657176 phenobarbital affects expression ISO RGD:1551257 6480464 Phenobarbital affects the expression of NRP2 mRNA CTD PMID:23091169 phenylmercury acetate increases expression ISO RGD:732191 6480464 Phenylmercuric Acetate results in increased expression of NRP2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:732191 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA CTD PMID:27188386 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of NRP2 mRNA CTD PMID:12832660 pirinixic acid increases expression ISO RGD:1551257 6480464 pirinixic acid results in increased expression of NRP2 mRNA CTD PMID:18301758 more ... procymidone decreases expression EXP 6480464 procymidone results in decreased expression of NRP2 mRNA CTD PMID:15686871 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of NRP2 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:732191 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:732191 6480464 Silicon Dioxide results in decreased expression of NRP2 mRNA CTD PMID:25351596 sodium arsenate decreases expression ISO RGD:1551257 6480464 sodium arsenate results in decreased expression of NRP2 mRNA CTD PMID:21795629 sodium arsenite affects methylation ISO RGD:732191 6480464 sodium arsenite affects the methylation of NRP2 gene CTD PMID:28589171 sphingosine 1-phosphate multiple interactions ISO RGD:732191 6480464 sphingosine 1-phosphate inhibits the reaction [N-acetylsphingosine results in decreased expression of NRP2 mRNA], sphingosine 1-phosphate inhibits the reaction [Thalidomide results in decreased expression of NRP2 mRNA] CTD PMID:15741222 succimer multiple interactions ISO RGD:1551257 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NRP2 mRNA CTD PMID:26378955 sunitinib increases expression ISO RGD:732191 6480464 Sunitinib results in increased expression of NRP2 mRNA CTD PMID:31533062 tamoxifen increases expression ISO RGD:1551257 6480464 Tamoxifen results in increased expression of NRP2 mRNA CTD PMID:25123088 terbufos increases methylation ISO RGD:732191 6480464 terbufos results in increased methylation of NRP2 promoter CTD PMID:22847954 Tesaglitazar decreases expression EXP 6480464 tesaglitazar results in decreased expression of NRP2 mRNA CTD PMID:21515302 tetrachloromethane affects expression ISO RGD:1551257 6480464 Carbon Tetrachloride affects the expression of NRP2 mRNA CTD PMID:17484886 thalidomide multiple interactions ISO RGD:732191 6480464 sphingosine 1-phosphate inhibits the reaction [Thalidomide results in decreased expression of NRP2 mRNA] CTD PMID:15741222 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of NRP2 mRNA CTD PMID:23411599 trichloroethene increases expression ISO RGD:1551257 6480464 Trichloroethylene results in increased expression of NRP2 mRNA CTD PMID:25549359 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of NRP2 gene CTD PMID:27618143 trichostatin A increases expression ISO RGD:732191 6480464 trichostatin A results in increased expression of NRP2 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:732191 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA CTD PMID:27188386 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of NRP2 mRNA CTD PMID:21515302 troglitazone decreases expression ISO RGD:1551257 6480464 troglitazone results in decreased expression of NRP2 mRNA CTD PMID:28973697 valproic acid affects expression ISO RGD:732191 6480464 Valproic Acid affects the expression of NRP2 mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:732191 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:732191 6480464 Valproic Acid results in increased expression of NRP2 mRNA CTD PMID:23179753 more ... valproic acid decreases expression ISO RGD:732191 6480464 Valproic Acid results in decreased expression of NRP2 mRNA CTD PMID:24935251 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of NRP2 mRNA CTD PMID:15686871 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of NRP2 mRNA CTD PMID:19015723 vorinostat increases expression ISO RGD:732191 6480464 vorinostat results in increased expression of NRP2 mRNA CTD PMID:26272509 vorinostat multiple interactions ISO RGD:732191 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA CTD PMID:27188386 zinc atom multiple interactions ISO RGD:732191 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of NRP2 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:732191 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of NRP2 mRNA CTD PMID:18593933
Biological Process angiogenesis IEA InterPro:IPR014648 , InterPro:IPR027143 1600115 GO_REF:0000002 InterPro GO_REF:0000002 axon extension involved in axon guidance ISO RGD:1551257 1624291 (MGI:MGI:5437554, PMID:22790009) RGD MGI:MGI:5437554 , PMID:22790009 axon guidance IEP 633436 RGD axon guidance ISO RGD:1551257 1624291 (MGI:MGI:3578029, PMID:15814794) RGD MGI:MGI:3578029 , PMID:15814794 cellular response to leukemia inhibitory factor ISO RGD:1551257 1624291 (MGI:MGI:4822296, PMID:20439489) RGD MGI:MGI:4822296 , PMID:20439489 dorsal root ganglion morphogenesis ISO RGD:1551257 1624291 (MGI:MGI:3848580, PMID:19386662) RGD MGI:MGI:3848580 , PMID:19386662 facial nerve structural organization ISO RGD:1551257 1624291 (MGI:MGI:3788968, PMID:18356247) RGD MGI:MGI:3788968 , PMID:18356247 facioacoustic ganglion development ISO RGD:1551257 1624291 (MGI:MGI:3788968, PMID:18356247) RGD MGI:MGI:3788968 , PMID:18356247 gonadotrophin-releasing hormone neuronal migration to the hypothalamus ISO RGD:1551257 1624291 (MGI:MGI:4850173, PMID:21059704) RGD MGI:MGI:4850173 , PMID:21059704 heart development ISO RGD:1551257 1624291 MGI:MGI:106206 (MGI:MGI:3505728 , PMID:12852851) RGD MGI:MGI:3505728 , PMID:12852851 negative chemotaxis ISO RGD:1551257 1624291 MGI:MGI:1096347 (MGI:MGI:3578029 more ... RGD MGI:MGI:3578029 more ... nerve development ISO RGD:1551257 1624291 (MGI:MGI:5437554, PMID:22790009) RGD MGI:MGI:5437554 , PMID:22790009 neural crest cell migration ISO RGD:1551257 1624291 MGI:MGI:2137037 (MGI:MGI:3613099 , PMID:16319111) RGD MGI:MGI:3613099 , PMID:16319111 neural crest cell migration involved in autonomic nervous system development ISO RGD:1551257 1624291 (MGI:MGI:3788968 more ... RGD MGI:MGI:3788968 more ... neuron migration ISO RGD:1551257 1624291 (MGI:MGI:4850173, PMID:21059704) RGD MGI:MGI:4850173 , PMID:21059704 outflow tract septum morphogenesis ISO RGD:1551257 1624291 UniProtKB:Q62181 (MGI:MGI:5693177 , PMID:26053665) RGD MGI:MGI:5693177 , PMID:26053665 regulation of postsynapse organization ISO RGD:1551257 1624291 (MGI:MGI:4420711, PMID:20010807) RGD MGI:MGI:4420711 , PMID:20010807 semaphorin-plexin signaling pathway involved in neuron projection guidance ISO RGD:1551257 1624291 (MGI:MGI:5437554, PMID:22790009) RGD MGI:MGI:5437554 , PMID:22790009 sensory neuron axon guidance ISO RGD:1551257 1624291 (MGI:MGI:3788968, PMID:18356247) RGD MGI:MGI:3788968 , PMID:18356247 sympathetic ganglion development ISO RGD:1551257 1624291 (MGI:MGI:5437554, PMID:22790009) RGD MGI:MGI:5437554 , PMID:22790009 sympathetic neuron projection extension ISO RGD:1551257 1624291 (MGI:MGI:5437554, PMID:22790009) RGD MGI:MGI:5437554 , PMID:22790009 sympathetic neuron projection guidance ISO RGD:1551257 1624291 (MGI:MGI:5437554, PMID:22790009) RGD MGI:MGI:5437554 , PMID:22790009 trigeminal ganglion development ISO RGD:1551257 1624291 (MGI:MGI:3788968, PMID:18356247) RGD MGI:MGI:3788968 , PMID:18356247 vascular endothelial growth factor signaling pathway IEA InterPro:IPR014648 , InterPro:IPR027143 1600115 GO_REF:0000002 InterPro GO_REF:0000002 ventral trunk neural crest cell migration ISO RGD:1551257 1624291 (MGI:MGI:3848580, PMID:19386662) RGD MGI:MGI:3848580 , PMID:19386662 vestibulocochlear nerve structural organization ISO RGD:1551257 1624291 (MGI:MGI:3788968, PMID:18356247) RGD MGI:MGI:3788968 , PMID:18356247 Cellular Component axon ISO RGD:1551257 1624291 (MGI:MGI:3574008, PMID:15677725) RGD MGI:MGI:3574008 , PMID:15677725 glutamatergic synapse ISO RGD:1551257 1624291 (MGI:MGI:4420711 more ... RGD MGI:MGI:4420711 more ... integral component of postsynaptic membrane ISO RGD:1551257 1624291 (MGI:MGI:5607822, PMID:25143608) RGD MGI:MGI:5607822 , PMID:25143608 Molecular Function heparin binding IEA UniProtKB-KW:KW-0358 1600115 GO_REF:0000043 UniProt GO_REF:0000043 identical protein binding ISO RGD:732191 1624291 UniProtKB:O60462-6 (PMID:25752543) RGD PMID:25752543 metal ion binding IEA UniProtKB-KW:KW-0479 1600115 GO_REF:0000043 UniProt GO_REF:0000043 protein binding ISO RGD:732191 1624291 UniProtKB:P97953-1 (PMID:25752543) RGD PMID:25752543 protein binding ISO RGD:1551257 1624291 PR:P70206 more ... RGD MGI:MGI:1346254 more ... semaphorin receptor activity ISO RGD:1551257 1624291 (MGI:MGI:3050159, PMID:15239958) RGD MGI:MGI:3050159 , PMID:15239958 vascular endothelial growth factor-activated receptor activity IEA InterPro:IPR014648 , InterPro:IPR027143 1600115 GO_REF:0000002 InterPro GO_REF:0000002
Gene-Chemical Interaction Annotations
